Canada markets close in 11 minutes

Elevance Health, Inc. (A58.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
495.00-0.90 (-0.18%)
As of 08:03AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 115.34B
Enterprise Value 133.93B
Trailing P/E 20.35
Forward P/E 14.49
PEG Ratio (5 yr expected) 0.90
Price/Sales (ttm)0.74
Price/Book (mrq)3.09
Enterprise Value/Revenue 0.85
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.83
52-Week Change 316.96%
S&P500 52-Week Change 324.69%
52 Week High 3506.20
52 Week Low 3370.00
50-Day Moving Average 3484.83
200-Day Moving Average 3448.64

Share Statistics

Avg Vol (3 month) 33
Avg Vol (10 day) 36
Shares Outstanding 5232.42M
Implied Shares Outstanding 6232.59M
Float 8231.84M
% Held by Insiders 10.20%
% Held by Institutions 191.32%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 46.14
Forward Annual Dividend Yield 41.24%
Trailing Annual Dividend Rate 36.07
Trailing Annual Dividend Yield 31.22%
5 Year Average Dividend Yield 41.14
Payout Ratio 422.90%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 10, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 3.64%
Operating Margin (ttm)7.52%

Management Effectiveness

Return on Assets (ttm)5.78%
Return on Equity (ttm)15.95%

Income Statement

Revenue (ttm)171.75B
Revenue Per Share (ttm)731.76
Quarterly Revenue Growth (yoy)1.00%
Gross Profit (ttm)N/A
EBITDA 11.15B
Net Income Avi to Common (ttm)6.24B
Diluted EPS (ttm)24.35
Quarterly Earnings Growth (yoy)12.90%

Balance Sheet

Total Cash (mrq)36.27B
Total Cash Per Share (mrq)156.04
Total Debt (mrq)26.45B
Total Debt/Equity (mrq)64.97%
Current Ratio (mrq)1.38
Book Value Per Share (mrq)174.62

Cash Flow Statement

Operating Cash Flow (ttm)3.57B
Levered Free Cash Flow (ttm)-261.12M